(Q45352633)

English

Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab

scientific article published on 13 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Epstein–Barr virus

1 reference

based on heuristic

inferred from title

15

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

F Patriarca

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

M Medeot

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

M Isola

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

M L Battista

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

A Sperotto

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

C Pipan

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

E Toffoletti

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

M Dozzo

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

A Michelutti

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

G Gregoraci

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

A Geromin

11

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

M Cerno

12

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

C Savignano

13

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

C Rinaldi

14

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

R Fanin

16

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

13 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

259-267

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Defining the intensity of conditioning regimens: working definitions

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Immunobiology of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Exact logistic regression: theory and examples

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Kinetics of Epstein-Barr virus DNA load in different blood compartments of pediatric recipients of T-cell-depleted HLA-haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

A prospective study on modulation of immunosuppression for Epstein-Barr virus reactivation in pediatric patients who underwent unrelated hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12061

21 January 2018

Identifiers

10.1111/TID.12061

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45352633&oldid=2075533055"